N/A
Manufactured by American Regent, Inc.
1,338 FDA adverse event reports analyzed
Last updated: 2026-04-15
AMINOCAPROIC ACID is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by American Regent, Inc.. The most commonly reported adverse reactions for AMINOCAPROIC ACID include HAEMORRHAGE, OFF LABEL USE, DRUG INEFFECTIVE, DEATH, EPISTAXIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMINOCAPROIC ACID.
Out of 681 classified reports for AMINOCAPROIC ACID:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,338 FDA FAERS reports that mention AMINOCAPROIC ACID. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include HAEMORRHAGE, OFF LABEL USE, DRUG INEFFECTIVE, DEATH, EPISTAXIS, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list American Regent, Inc. in connection with AMINOCAPROIC ACID. Always verify the specific product and NDC with your pharmacist.